| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/11/2000 | US6087105 Nucleotide sequences coding a protein associated with adherence and infection of bacterial parasite; for detection of modulators of bacterial adhesion |
| 07/11/2000 | US6086913 Introduction of nucleic acid fragments into geomes of cells |
| 07/11/2000 | US6086900 Cells and conjugated molecules |
| 07/11/2000 | US6086899 Ethylene oxide-propylene oxide copolymer |
| 07/11/2000 | US6086890 Bovine adenovirus expression vector system |
| 07/11/2000 | US6086876 Suppressing interleukin-12 (il-12) production in a human by administering a ligand that binds the complement receptor protein cd46, the ligand suspended in a carrier and binding suppresses il-12 production; treating autoimmune diseases |
| 07/11/2000 | US6086870 Co-precipitates of adenovirus with metal salts |
| 07/11/2000 | US6086867 By contacting the cell with a soluble polypeptide comprising the amino acid sequence of the extracellular domain of the transforming growth factor-beta (tgf-b) type iii receptor protein or mammalian dna encoding it |
| 07/06/2000 | WO2000039347A1 A tumor suppressor protein involved in death signaling, and diagnostics, therapeutics, and screening based on this protein |
| 07/06/2000 | WO2000039331A1 Single nucleotide polymorphism in a pyruvate dehydrogenase kinase isoenzyme 2 (pdk2) in humans |
| 07/06/2000 | WO2000039327A1 Peptidoglycan recognition proteins |
| 07/06/2000 | WO2000039318A1 Compositions and methods for packaging of alphavirus vectors |
| 07/06/2000 | WO2000039317A1 Gene transfer vector for the diagnosis and therapy of malign tumors |
| 07/06/2000 | WO2000039311A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | WO2000039308A1 Ikk3 kinase |
| 07/06/2000 | WO2000039304A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 07/06/2000 | WO2000039303A2 Modified hiv env polypeptides |
| 07/06/2000 | WO2000039302A2 Improved expression of hiv polypeptides and production of virus-like particles |
| 07/06/2000 | WO2000039298A1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum |
| 07/06/2000 | WO2000039294A1 Porcine cells incapable of expressing cd40 antigen, for xenotransplantation |
| 07/06/2000 | WO2000039287A2 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides and uses thereof |
| 07/06/2000 | WO2000039285A2 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof |
| 07/06/2000 | WO2000039279A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | WO2000039278A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 07/06/2000 | WO2000039275A2 Multiple shear stress responsive elements (ssre) and methods of use thereof |
| 07/06/2000 | WO2000039160A2 Caspase-8 interacting proteins |
| 07/06/2000 | WO2000039158A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000039157A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000039145A1 Targeted gene transfer using g protein coupled receptors |
| 07/06/2000 | WO2000039136A2 Human brainiac-5 |
| 07/06/2000 | WO2000038737A2 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase |
| 07/06/2000 | WO2000038709A1 Treatment of hyperproliferative disorders using casein kinase i |
| 07/06/2000 | WO2000038707A1 Method for the treatment of bone loss |
| 07/06/2000 | WO2000038706A2 Methods for treating cancer and for mediating chemotaxis of dendritic cells |
| 07/06/2000 | WO2000038518A1 Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
| 07/06/2000 | WO2000038517A1 Methods for reducing adverse side effects associated with cellular transplantation |
| 07/06/2000 | WO2000038515A1 Peptide mimics useful for treating disease |
| 07/06/2000 | WO2000022124A3 Methods and compositions to induce antitumor response |
| 07/06/2000 | WO2000020619A3 Secreted renilla luciferase |
| 07/06/2000 | WO2000018903A3 Inducible genetic suppression of cellular excitability |
| 07/06/2000 | WO2000017222A8 31 human secreted proteins |
| 07/06/2000 | WO2000013703A3 Methods of treating hypertension and compositions for use therein |
| 07/06/2000 | WO2000010613A3 Inhibition of smooth muscle cell migration by heme oxygenase 1 |
| 07/06/2000 | WO1999063115A9 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 07/06/2000 | WO1999054461A3 Human nucleic acid sequences of endometrium tumour tissue |
| 07/06/2000 | WO1999054447A3 Human nucleic acid sequences of bladder tumour tissue |
| 07/06/2000 | WO1999053040A3 Human nucleic acid sequences from ovarian tumour tissue |
| 07/06/2000 | WO1999051727A3 Human nucleic acid sequences of normal ovary tissue |
| 07/06/2000 | WO1999047655A3 Human nucleic acid fragments with heightened expression in normal breast tissue |
| 07/06/2000 | WO1999046375A3 Human nucleic acid sequences from prostate tissue |
| 07/06/2000 | WO1999046374A3 Human nucleic acid sequences from prostate tumour tissue |
| 07/06/2000 | WO1999041282A8 Therapeutic uses of keratinocyte growth factor-2 |
| 07/06/2000 | DE19860602A1 Gentransfervektor für die Diagnostik und die Therapie von malignen Tumoren Gene transfer vector for the diagnosis and therapy of malignant tumors |
| 07/06/2000 | CA2358687A1 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | CA2358385A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 07/06/2000 | CA2358094A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | CA2356877A1 Gene therapy for pulmonary edema using adenovirus vectors encoding na,k-atpase |
| 07/06/2000 | CA2356834A1 Methods for reducing adverse side effects associated with cellular transplantation |
| 07/06/2000 | CA2356608A1 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides abd uses thereof |
| 07/06/2000 | CA2356551A1 Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
| 07/06/2000 | CA2356548A1 Human brainiac-5 |
| 07/06/2000 | CA2356542A1 Peptidoglycan recognition proteins |
| 07/06/2000 | CA2356057A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | CA2355468A1 Glycosyl phosphatidy linositol specific phospholipase d proteins and uses thereof |
| 07/06/2000 | CA2355227A1 Targeted gene transfer using g protein coupled receptors |
| 07/06/2000 | CA2354431A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | CA2334958A1 Peptide mimics useful for treating disease |
| 07/06/2000 | CA2321672A1 Caspase-8 interacting proteins |
| 07/05/2000 | EP1016727A1 Gene therapy to promote angiogenesis. |
| 07/05/2000 | EP1016726A1 Gene therapy to promote angiogenesis |
| 07/05/2000 | EP1016719A1 Dna participating in regulation of expression of a pebp2 alpha a gene, and use thereof |
| 07/05/2000 | EP1016714A1 Novel plasmid dna containing reporter gene dna and use of the same |
| 07/05/2000 | EP1016711A1 Process for inactivating enveloped viruses in a viral preparation containing non-enveloped viruses |
| 07/05/2000 | EP1016418A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/05/2000 | EP1015630A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/05/2000 | EP1015619A1 Methods and cell line useful for production of recombinant adeno-associated viruses |
| 07/05/2000 | EP1015616A2 Intrabody-mediated control of immune reactions |
| 07/05/2000 | EP1015615A1 Targeted gene transfer using g protein coupled receptors |
| 07/05/2000 | EP1015602A1 Glutrna gln amidotransferase - a novel essential translational component |
| 07/05/2000 | EP1015595A1 Peptides derived from the attachment (g) protein of respiratory syncytial virus |
| 07/05/2000 | EP1015593A1 Hepatitis b virus polypeptides |
| 07/05/2000 | EP1015584A1 Dna vaccination against cholesterol ester transfer protein in the treatment of atherosclerosis |
| 07/05/2000 | EP1015583A2 Protein containing an srcr domain |
| 07/05/2000 | EP1015566A1 Human ste20-like stress activated serine/threonine kinase |
| 07/05/2000 | EP1015559A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use |
| 07/05/2000 | EP1015485A1 Macrophage derived chemokine (mdc) as an anti-viral agent for the treatment and prevention of lentivirus infections |
| 07/05/2000 | EP1015474A1 Don-1 gene and polypeptides and uses therefor |
| 07/05/2000 | EP1015471A1 Hypoxia-regulated genes |
| 07/05/2000 | EP1015470A1 Composition and method for delivery of nucleic acids |
| 07/05/2000 | EP1015469A2 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 07/05/2000 | EP1015468A1 Follistatin-3 |
| 07/05/2000 | EP1015465A2 Hydrophobic glycosylamine derivatives, compositions, and methods for use |
| 07/05/2000 | EP1015037A2 METHOD FOR INFLUENCING THE p53 LINKAGE IN TARGET GENES |
| 07/05/2000 | EP1015036A1 Improvements in or relating to expression of immunogenic substances |
| 07/05/2000 | EP1015035A1 Vaccination by topical application of genetic vectors |
| 07/05/2000 | EP1015034A1 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
| 07/05/2000 | EP1015024A1 Antigen presenting mesenchymal stem cells |
| 07/05/2000 | EP1015023A1 Use or a secretion vector for fertility control by oral vaccination |
| 07/05/2000 | EP1015017A1 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 07/05/2000 | EP1015014A1 Methods and compositions for inhibiting angiogenesis |